Former Amgen IT Executive to Lead Neural ID Software Architecture
Redwood City, CA (PRWEB) September 11, 2013 -- Neural ID, the leader in waveform analytics solutions for the life sciences industry, today announced the addition of Karl Geiger to the company's executive team as chief software architect. A business technology expert with over 30 years in academia, industry, and consulting, Geiger was most recently the Chair of the IEEE Los Angeles Council. Effective immediately, Geiger assumes primary responsibility for development of the company’s patented pattern recognition platform.
"Neural ID’s products present an exciting advancement in the analysis and management of the overwhelming torrents of drug discovery and development data," said Geiger. "I am delighted to be part of such a terrific team. I look forward to working with them, our partners, and especially our customers to deliver mission-critical tools that will play a significant role in bringing vital medicines to patients."
Emerging technologies are a critical component to help address the biopharmaceutical productivity crisis. An outgrowth of the technology adoption is a critical need to analyze an increasing volume of disparate data. Neural ID delivers the only enterprise solution providing actionable information from waveform content. Their Intelligent Waveform Service (IWS) automates the analysis of biosignals and disseminates knowledge across the enterprise through industry-standard dashboards. The patented pattern-based platform is quickly customer-configured, applying machine learning and next-generation neural network technology to speed drug development and delivery.
"Karl has the experience, vision and drive to build a platform that addresses the acute needs in life sciences, reducing R&D cost and cycle time," said Tim Carruthers, CEO of Neural ID. "With Karl's leadership, we will further expand on our enterprise offerings across discovery and clinical applications."
About Neural ID
Neural ID offers the only scalable enterprise solution for waveform analytics. Powered by patented pattern recognition technology, the Intelligent Waveform Service (IWS) provides automated biosignal recognition and analysis to accelerate drug development. Based in Redwood City, California, Neural ID accelerates research, expands capacity and reduces costs to leading organizations worldwide. For additional information, please visit http://www.neuralid.com or call 650-394-8800.
Jon Knisley, Neural ID, http://www.neuralid.com, +1 (703) 665-9870, [email protected]
Share this article